TRACON (TCON) - Stock Price

This TCON price chart illustrates the performance of TRACON Pharmaceuticals (TCON), a company developing precision treatments for rare cancers that has earned expert recognition for the quality of its tests. The operating model relies on engaging external CROs for early-stage research, which mitigates the risks of dependency on a single contractor. The current metric stands at 0.06, while the business implements eco-standards to minimize harmful laboratory emissions.

Market Price: TRACON Pharmaceuticals (TCON) for 07/04/2022 - 08/04/2024

TRACON Pharmaceuticals, Inc (TCON) - metric breakdowns and financial figures

- current price and projected stock value:

Stock Quotes TRACON Pharmaceuticals|TCON - Analyst Forecast Prices

- market capitalization indicators:

Market Capitalization TRACON Pharmaceuticals|TCON - Real Price to Acquire Entire Company

- book capitalization information:

Net Assets per Single Share TRACON Pharmaceuticals|TCON - Total Stockholders' Equity|Market Value to Book Value Ratio traconpharma.com|TCON - Total Business Assets

- issuer credit burden and liquidity indicators:

- company profitability and valuation multiples indicators:

TCON - Final Profit|Projected Future Earnings TRACON Pharmaceuticals|TCON - P/E Multiple|Forward P/E Multiple TRACON Pharmaceuticals, Inc|TCON - Price/Earnings to Growth Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization TRACON Pharmaceuticals Inc.|TCON - Profit before interest, taxes and amortization|Earnings per share for the last twelve months TRACON Pharmaceuticals|TCON - Earnings per share for the last 12 months|Year-over-year net earnings per share growth for the last 12 months traconpharma.com|TCON - Earnings per share increase in current year|Net earnings per share growth forecast for next year TRACON Pharmaceuticals

- sales and revenue data:

TCON - Company Annual Revenue|Projected Sales Volume TRACON Pharmaceuticals, Inc.|TCON - Market Capitalization-to-Revenue Ratio|Forward P/S Multiple TRACON

Summary company analytics:traconpharma.com

The price reflects the asset's market value and serves as an indicator of compliance with US exchange listing requirements regarding minimum capitalization. For TRACON Pharmaceuticals (TCON), the price history becomes a measure of regulatory risks amid the cessation of research and workforce reductions, turning the chart into a monitor for the liquidation process or the sale of patent rights.

Analysis of competing companies